InspireMD, Inc. Series B Warrants
NSPRZ
NSPRZ was delisted on the 14th of March, 2022.
4 hedge funds and large institutions have $6.33K invested in InspireMD, Inc. Series B Warrants in 2019 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 1 reducing their positions, and 0 closing their positions.
0% more funds holding
Funds holding: 4 → 4 (0)
29% less capital invested
Capital invested by funds: $8.85K → $6.33K (-$2.53K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$98 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $5K | -$98 | -10,600 | -2% |
|
2
UBS Group
Zurich,
Switzerland
| $1K | – | – | – |
|
|
AFM
3
Anson Funds Management
Dallas,
Texas
| $325 | – | – | – |
|
NSPRZ Hedge Fund Activity: Q3 2019 in Review
4 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in InspireMD, Inc. Series B Warrants (NSPRZ) for Q3 2019, worth a combined $6.33K — down 29% from $8.85K a quarter earlier.
Fund positioning in NSPRZ was balanced in Q3 2019: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.
The largest seller was Susquehanna International Group, cutting an estimated $98.
- 4 institutional investors held InspireMD, Inc. Series B Warrants (NSPRZ) as of Q3 2019, unchanged from Q2 2019.
- Funds reported $6.33K of InspireMD, Inc. Series B Warrants stock for Q3 2019, down 29% quarter-over-quarter.
- 0 funds opened new InspireMD, Inc. Series B Warrants positions in Q3 2019 and 0 closed out.
- The largest InspireMD, Inc. Series B Warrants seller in Q3 2019 was Susquehanna International Group, an estimated $98 sold.
Based on aggregated 13F filings for Q3 2019.